Study of Oglemilast for the Treatment of Asthma

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to determine whether oglemilast is safe and effective in the treatment of allergen-induced asthma.

Phase 2

Forest Laboratories